T2 Biosystems, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 28 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-12-11: Reporting owner CARELLA THOMAS J.; Form 4; Security Stock options (Right to buy); Transaction Holding.
- 2015-12-08: Reporting owner Elsbree David B; Form 4; Security Employee Stock Option (right to buy); Transaction G Bona fide gift.
- 2015-12-08: Reporting owner Elsbree David B; Form 4; Security Employee Stock Option (right to buy); Transaction G Bona fide gift.
- 2015-12-08: Reporting owner Elsbree David B; Form 4; Security Employee Stock Option (right to buy); Transaction G Bona fide gift.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-12-11 holding as of filing | CARELLA THOMAS J. Director | 4 | Stock options (Right to buy) Derivative · Indirect · See footnotes | Holding | 17,647 owned after | $18.59 exercise price | 2015-12-11 | |
| 2015-12-08 | Elsbree David B Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | G Bona fide gift | −22,222 27,778 owned after | $10.70 exercise price | 2015-12-10 | |
| 2015-12-08 | Elsbree David B Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | G Bona fide gift | −7,189 8,987 owned after | $10.70 exercise price | 2015-12-10 | |
| 2015-12-08 | Elsbree David B Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | G Bona fide gift | −5,882 11,765 owned after | $18.59 exercise price | 2015-12-10 | |
| 2015-10-30 | Harding David Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +146,600 146,600 owned after | $11.12 exercise price | 2015-11-09 | |
| 2015-08-12 | Lowery Thomas J. Officer (Chief Scientific Officer) | 4/A | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 36,235 owned after | $2.45 exercise price | 2015-09-03 | |
| 2015-08-12 | Lowery Thomas J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 36,235 owned after | $2.45 exercise price | 2015-08-14 | |
| 2015-08-06 | CASTONGUAY MAURICE L Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +146,000 146,000 owned after | $14.04 exercise price | 2015-08-10 | |
| 2015-07-10 | Lowery Thomas J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 18,588 owned after | $1.31 exercise price | 2015-07-14 | |
| 2015-06-19 | GOLDMAN SACHS & CO | GOLDMAN SACHS GROUP INC 10% Owner | 10% Owner | 4 | Stock Option (right to buy) Derivative · Indirect · See footnotes | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,647 17,647 owned after | $18.59 exercise price | 2015-06-29 | |
| 2015-06-19 | LAPIDUS STANLEY N Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,647 17,647 owned after | $18.59 exercise price | 2015-06-23 | |
| 2015-06-19 | Cima Michael J. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,647 17,647 owned after | $18.59 exercise price | 2015-06-23 | |
| 2015-06-19 | Bilenker Joshua H. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,647 17,647 owned after | $18.59 exercise price | 2015-06-23 | |
| 2015-06-19 | CUMMING JOHN W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,647 17,647 owned after | $18.59 exercise price | 2015-06-23 | |
| 2015-06-19 | WILCOX HARRY W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,647 | $18.59 exercise price | 2015-06-23 | |
| 2015-06-19 | Elsbree David B Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,647 17,647 owned after | $18.59 exercise price | 2015-06-23 | |
| 2015-06-19 | CARELLA THOMAS J. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,647 17,647 owned after | $18.59 exercise price | 2015-06-23 | |
| 2015-06-18 | Lowery Thomas J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +1,000 18,647 owned after | $1.16 exercise price | 2015-06-22 | |
| 2015-06-02 | Lowery Thomas J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +882 19,647 owned after | $1.16 exercise price | 2015-06-04 | |
| 2015-05-20 | Lowery Thomas J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +1,000 20,529 owned after | $1.16 exercise price | 2015-05-22 | |
| 2015-05-08 | Pfaller Michael A. Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +15,440 37,501 owned after | $10.69 exercise price | 2015-05-11 | |
| 2015-05-04 | Lowery Thomas J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +1,000 21,529 owned after | $1.16 exercise price | 2015-05-18 | |
| 2015-04-20 | Lowery Thomas J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +1,000 22,529 owned after | $1.16 exercise price | 2015-04-22 | |
| 2015-03-27 | Kalil Sarah O. Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −41,500 124,529 owned after | $3.22 exercise price | 2015-03-31 | |
| 2015-03-27 | McDonough John Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 16,806 owned after | $1.16 exercise price | 2015-03-31 | |
| 2015-02-13 | Lowery Thomas J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,460 44,460 owned after | $19.95 exercise price | 2015-03-17 | |
| 2015-02-13 | McDonough John Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +134,124 134,124 owned after | $19.95 exercise price | 2015-03-17 | |
| 2015-02-13 | Kalil Sarah O. Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,460 44,460 owned after | $19.95 exercise price | 2015-03-17 |